| 期刊全稱 | Allergy Frontiers:Therapy and Prevention | | 影響因子2023 | Ruby Pawankar,Stephen T. Holgate,Lanny J. Rosenwas | | 視頻video | http://file.papertrans.cn/154/153501/153501.mp4 | | 發(fā)行地址 | Includes supplementary material: | | 學科分類 | Allergy Frontiers | | 圖書封面 |  | | 影響因子 | When I entered the field of allergy in the early 1970s, the standard textbook was a few hundred pages, and the specialty was so compact that texts were often authored entirely by a single individual and were never larger than one volume. Compare this with Allergy Frontiers: Epigenetics, Allergens, and Risk Factors, the present s- volume text with well over 150 contributors from throughout the world. This book captures the explosive growth of our specialty since the single-author textbooks referred to above. The unprecedented format of this work lies in its meticulous attention to detail yet comprehensive scope. For example, great detail is seen in manuscripts dealing with topics such as “Exosomes, naturally occurring minimal antigen presenting units” and “Neuropeptide S receptor 1 (NPSR1), an asthma susceptibility gene.” The scope is exemplified by the unique approach to disease entities normally dealt with in a single chapter in most texts. For example, anaphylaxis, a topic usually confined to one chapter in most textbooks, is given five chapters in Allergy Frontiers. This approach allows the text to employ multiple contributors for a single topic, giving the reader the advantage | | Pindex | Book 2010 |
The information of publication is updating
|
|
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-13 23:12
發(fā)表于 2025-3-21 18:57:17
